Therapeutic aspects of cannabis and cannabinoids.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11157423.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Review commissioned in 1996 by the Department of Health (DOH). Assess therapeutic profile of cannabis and cannabinoids. Medline search, references supplied by DOH and others, and personal communications. Cannabis and some cannabinoids are effective anti-emetics and analgesics and reduce intra-ocular pressure. There is evidence of symptom relief and improved well-being in selected neurological conditions, AIDS and certain cancers. Cannabinoids may reduce anxiety and improve sleep. Anticonvulsant activity requires clarification. Other properties identified by basic research await evaluation. Standard treatments for many relevant disorders are unsatisfactory. Cannabis is safe in overdose but often produces unwanted effects, typically sedation, intoxication, clumsiness, dizziness, dry mouth, lowered blood pressure or increased heart rate. The discovery of specific receptors and natural ligands may lead to drug developments. Research is needed to optimise dose and route of administration, quantify therapeutic and adverse effects, and examine interactions.
Medical subject headings
- Analgesics, Non-Narcotic
- Cannabinoids
- Cannabis
- Multiple Sclerosis
- Nausea
- Phytotherapy